Search results for “Kinase” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 58,379 patents, we discovered top 472 key players by total patent application. Novartis AG, F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Co. are dominant in this area. They take 10.47% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 2,859
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 1,745
Bristol Myers Squibb Co.
New York, United States
Patent: 1,511
Merck Patent GmbH
Hessen, Germany
Patent: 1,343
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1,247
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1,247
Incyte Corp.
Delaware, United States
Patent: 1,102
Array BioPharma, Inc.
Colorado, United States
Patent: 1,078
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 1,066
Genentech, Inc.
California, United States
Patent: 1,053
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1,002 patents, we discovered top 118 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Shenzhen Tajirui Biomedical Co. Ltd., BenevolentAI Bio Ltd. are active in this area.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 157
STARTUP
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 111
BenevolentAI Bio Ltd.
United Kingdom
Patent: 39
STARTUP
Sumitomo Dainippon Pharma Oncology, Inc.
United States
Patent: 39
STARTUP
iOmx Therapeutics AG
Bayern, Germany
Patent: 37
STARTUP
HepaRegeniX GmbH
Baden-Württemberg, Germany
Patent: 36
STARTUP
Shanghai Drug Farm Biological Technology Co., Ltd.
Shanghai Shi, China
Patent: 25
STARTUP
Petra Pharma Corp.
New York, United States
Patent: 24
STARTUP
Verge Genomics Inc.
California, United States
Patent: 23
STARTUP
Aiviva Biopharma, Inc.
California, United States
Patent: 23
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 13,573 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Incyte Corp., Dana-Farber Cancer Institute, Inc., Rigel Pharmaceuticals, Inc. take 5.67% of patent filing during this period.
Incyte Corp.
Delaware, United States
Patent: 349
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 219
Rigel Pharmaceuticals, Inc.
California, United States
Patent: 202
Array BioPharma, Inc.
Colorado, United States
Patent: 200
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 197
Bristol Myers Squibb Co.
New York, United States
Patent: 193
The Board of Regents of The University of Texas System
Texas, United States
Patent: 168
Pfizer Inc.
New York, United States
Patent: 144
Theravance Biopharma R&D IP LLC
California, United States
Patent: 136
Exelixis, Inc.
California, United States
Patent: 119
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 13,573 patents in last 5 years, we discover 157 new entrants. Kinnate Biopharma, Inc., Zhejiang Tongkang Medicine Co Ltd, Fulcrum Therapeutics, Inc. are the most active new entrants in this area.
Kinnate Biopharma, Inc.
California, United States
Patent: 74
Zhejiang Tongkang Medicine Co Ltd
Zhejiang Sheng, China
Patent: 56
Fulcrum Therapeutics, Inc.
Massachusetts, United States
Patent: 47
Repare Therapeutics, Inc.
Quebec, Canada
Patent: 45
Shanghai Ennovabio Pharmaceuticals Co. Ltd.
Shanghai Shi, China
Patent: 44
Enanta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 43
BenevolentAI Bio Ltd.
United Kingdom
Patent: 39
STARTUP
iOmx Therapeutics AG
Bayern, Germany
Patent: 37
STARTUP
HepaRegeniX GmbH
Baden-Württemberg, Germany
Patent: 36
Beijing Tide Pharmaceutical Co., Ltd.
Beijing Shi, China
Patent: 33
Research Institutions
Order by:
Innovation Intensity
With the analysis among 9,062 patents, we discovered top 255 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, The Scripps Research Institute, Icahn School of Medicine at Mount Sinai are dominant in this area. They take 10.77% of the total patent filing.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 212
The Scripps Research Institute
California, United States
Patent: 204
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 121
President & Fellows of Harvard College
Massachusetts, United States
Patent: 115
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 111
The Johns Hopkins University
United States
Patent: 96
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 95
University of South Florida
United States
Patent: 84
Institute Of Cancer Research
United Kingdom
Patent: 82
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 76
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: